Peptide record

TPDB64871

[Tyr10] Secretin-27 Blood-Brain Barrier standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB64871
[Tyr10] Secretin-27
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia
standard
No
A 27-aa standard-residue blood-brain barrier peptide sequence curated from B3Pred, BBPpredict, and Peptipedia, with an available 3D structural model.
Sequence
HSDGTFTSEYSRLRDSARLQRLLQGLV
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C133H217N43O43
NCIKMPW
L
3106.45
9.87
5
3
9
+1
3.08
-0.652
86.67
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
1490
0.48
9
Residue Composition
number
1
A
4
R
0
N
2
D
0
C
1
E
2
Q
2
G
1
H
0
I
5
L
0
K
0
M
1
F
0
P
4
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 4 N: 0 D: 2 C: 0 E: 1 Q: 2 G: 2 H: 1 I: 0 L: 5 K: 0 M: 0 F: 1 P: 0 S: 4 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
27 reviewed residue count
C133H217N43O43 sequence-only estimate (linear, free termini)
3106.45 sequence-only estimate (linear, free termini)
9.87 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
3.08 sequence-only estimate (linear, free termini)
-0.652 sequence-only estimate (linear, free termini)
Linear Activity
His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val Activity
[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.000954 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Gila monster
Intravenous
non saturable
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.0099 ml/g

Assay & Model

Initial distribution volume

Source & Reference

NA
B3Pdb

Other

Gila monster
Intravenous
non saturable
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
0.12 %/g

Assay & Model

% injected dose

Source & Reference

NA
B3Pdb

Other

Gila monster
Intravenous
non saturable
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
-2.76

Assay & Model

Shake Flask
Log P

Source & Reference

NA
B3Pdb

Other

Gila monster
Direct iodination
Additional Detail Fields 1 fields
Intravenous